Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor
Notifications can be managed in browser preferences.
Next article
Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Sales of weight-loss drug Ozempic are reportedly up by 500 to 600 per cent in Britain following the announcement of price rises of its popular competitor Mounjaro.
Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes…
Our community shared deeply mixed experiences of Ozempic and Mounjaro, with many warning of severe and sometimes debilitating…
Novo Nordisk cuts its forecasts after a boom in copycats and the rise of Mounjaro
Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription
Patients and prescribers have described the medication as ‘life-changing’, but price hikes risk depriving those who need it
Drugmaker halves price of Ozempic for Americans amid Trump crackdown
